Dissecting mechanisms of resistance to targeted drug combination therapy in human colorectal cancer. [electronic resource]
Producer: 20191217Description: 5076-5090 p. digitalISSN:- 1476-5594
- Aniline Compounds -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Colorectal Neoplasms -- drug therapy
- Drug Resistance, Neoplasm -- genetics
- HCT116 Cells
- Humans
- MAP Kinase Kinase 1 -- antagonists & inhibitors
- MAP Kinase Kinase 2 -- antagonists & inhibitors
- MAP Kinase Signaling System -- drug effects
- Molecular Targeted Therapy -- methods
- PTEN Phosphohydrolase -- antagonists & inhibitors
- Protein Kinase Inhibitors -- administration & dosage
- Proto-Oncogene Proteins c-bcl-2 -- antagonists & inhibitors
- Signal Transduction -- genetics
- Sulfonamides -- administration & dosage
- Tumor Cells, Cultured
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.